ORIC Pharmaceuticals saw the highest growth of 0.99% in patent filings in June and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.66% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of ORIC Pharmaceuticals’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
ORIC Pharmaceuticals has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 33% filings and 20% grants. The World Intellectual Property Organization(WIPO), United States(US), Israel(IL), and Australia(AU) patent Office are among the top ten patent offices where ORIC Pharmaceuticals is filings its patents. Among the top granted patent authorities, ORIC Pharmaceuticals has 40% of its grants in Israel(IL), 20% in United States(US) and 20% in Australia(AU).
Roche and Johnson & Johnson could be the strongest competitors for ORIC Pharmaceuticals
Patents related to rare diseases lead ORIC Pharmaceuticals's portfolio
ORIC Pharmaceuticals has the highest number of patents in rare diseases. For rare diseases no patents were filed and 100% of patents were granted in Q2 2024.
Neurodegenerative diseases related patents lead ORIC Pharmaceuticals portfolio followed by prostate cancer, and breast cancer
ORIC Pharmaceuticals has highest number of patents in neurodegenerative diseases followed by prostate cancer, breast cancer, lymphoma, and colorectal tumor. For neurodegenerative diseases, nearly 6% of patents were filed and 23% of patents were granted in Q2 2024.
For comprehensive analysis of ORIC Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
